Endurant Capital Management LP - Q2 2022 holdings

$285 Million is the total value of Endurant Capital Management LP's 50 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 66.7% .

 Value Shares↓ Weighting
HUM SellHUMANA INC$12,688,000
+0.1%
27,106
-6.9%
4.45%
+33.3%
SPY SellSPDR S&P 500 ETF TRput$9,771,000
-78.8%
25,900
-74.6%
3.43%
-71.7%
LH SellLABORATORY CORP AMER HLDGS$8,137,000
-49.6%
34,718
-43.3%
2.86%
-32.9%
BIO SellBIO RAD LABS INCcl a$7,934,000
-17.9%
16,028
-6.5%
2.78%
+9.4%
CNC SellCENTENE CORP DEL$5,779,000
-68.5%
68,305
-68.7%
2.03%
-58.1%
MCK SellMCKESSON CORP$5,214,000
-41.6%
15,984
-45.2%
1.83%
-22.2%
ADAP SellADAPTIMMUNE THERAPEUTICS PLCsponds adr$3,101,000
-30.3%
1,824,065
-15.6%
1.09%
-7.2%
OCUL SellOCULAR THERAPEUTIX INC$3,056,000
-33.2%
760,228
-17.7%
1.07%
-11.0%
GLPG SellGALAPAGOS NVspon adr$2,869,000
-11.7%
51,410
-1.9%
1.01%
+17.5%
INSM SellINSMED INC$2,802,000
-27.9%
142,071
-14.0%
0.98%
-3.9%
THC SellTENET HEALTHCARE CORP$2,494,000
-77.9%
47,442
-63.9%
0.88%
-70.6%
XBI SellSPDR SER TRs&p biotech$2,328,000
-44.2%
31,349
-32.5%
0.82%
-25.7%
ALBO SellALBIREO PHARMA INC$751,000
-79.2%
37,835
-68.7%
0.26%
-72.3%
AXSM SellAXSOME THERAPEUTICS INC$584,000
-85.9%
15,246
-84.8%
0.20%
-81.2%
PRAX SellPRAXIS PRECISION MEDICINES I$194,000
-76.1%
79,097
-0.4%
0.07%
-68.2%
IMUX SellIMMUNIC INC$106,000
-92.8%
30,591
-76.6%
0.04%
-90.5%
PHAS ExitPHASEBIO PHARMACEUTICALS INC$0-243,795
-100.0%
-0.08%
ExitDARIOHEALTH CORP$0-73,779
-100.0%
-0.11%
GOSS ExitGOSSAMER BIO INC$0-68,710
-100.0%
-0.16%
CRL ExitCHARLES RIV LABS INTL INC$0-3,308
-100.0%
-0.25%
KZR ExitKEZAR LIFE SCIENCES INC$0-59,474
-100.0%
-0.26%
NTRA ExitNATERA INC$0-24,747
-100.0%
-0.26%
IOVA ExitIOVANCE BIOTHERAPEUTICS INC$0-60,720
-100.0%
-0.27%
CDNA ExitCAREDX INC$0-28,048
-100.0%
-0.27%
MTEM ExitMOLECULAR TEMPLATES INC$0-314,238
-100.0%
-0.29%
DVA ExitDAVITA INCput$0-10,000
-100.0%
-0.30%
RYTM ExitRHYTHM PHARMACEUTICALS INC$0-105,792
-100.0%
-0.32%
ICUI ExitICU MED INC$0-6,093
-100.0%
-0.36%
ARGX ExitARGENX SEsponsored adr$0-4,480
-100.0%
-0.37%
VRDN ExitVIRIDIAN THERAPEUTICS INC$0-83,217
-100.0%
-0.40%
AFMD ExitAFFIMED N V$0-354,492
-100.0%
-0.41%
ALNY ExitALNYLAM PHARMACEUTICALS INC$0-10,379
-100.0%
-0.45%
VRTX ExitVERTEX PHARMACEUTICALS INC$0-6,982
-100.0%
-0.48%
BHVN ExitBIOHAVEN PHARMACTL HLDG CO L$0-15,400
-100.0%
-0.48%
TXG Exit10X GENOMICS INC$0-24,923
-100.0%
-0.50%
KRTX ExitKARUNA THERAPEUTICS INC$0-15,342
-100.0%
-0.51%
TNDM ExitTANDEM DIABETES CARE INC$0-18,236
-100.0%
-0.56%
MTD ExitMETTLER TOLEDO INTERNATIONAL$0-1,765
-100.0%
-0.64%
PINC ExitPREMIER INCcl a$0-75,632
-100.0%
-0.71%
IDXX ExitIDEXX LABS INC$0-5,729
-100.0%
-0.83%
AHCO ExitADAPTHEALTH CORP$0-248,314
-100.0%
-1.05%
EHC ExitENCOMPASS HEALTH CORP$0-65,653
-100.0%
-1.23%
ISRG ExitINTUITIVE SURGICAL INC$0-17,232
-100.0%
-1.37%
EW ExitEDWARDS LIFESCIENCES CORP$0-44,561
-100.0%
-1.38%
SYNH ExitSYNEOS HEALTH INCcl a$0-123,232
-100.0%
-2.63%
BMY ExitBRISTOL-MYERS SQUIBB CO$0-194,684
-100.0%
-3.74%
OFIX ExitORTHOFIX MED INC$0-434,803
-100.0%
-3.74%
AZN ExitASTRAZENECA PLCsponsored adr$0-240,271
-100.0%
-4.20%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LABORATORY CORP AMER HLDGS31Q2 20238.7%
ELEVANCE HEALTH INC29Q3 20238.8%
BECTON DICKINSON & CO28Q2 20239.8%
MCKESSON CORP27Q1 20234.4%
CENCORA INC26Q3 20235.9%
HOLOGIC INC24Q3 20237.5%
JOHNSON & JOHNSON24Q4 20215.5%
ZIMMER HLDGS INC23Q3 20237.5%
BOSTON SCIENTIFIC CORP22Q3 20235.5%
DAVITA INC22Q1 20214.9%

View Endurant Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Endurant Capital Management LP Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AZIYO BIOLOGICS, INC.March 21, 2023576,2534.9%
Oxford Immunotec Global PLCSold outFebruary 17, 202100.0%

View Endurant Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-07
SC 13D/A2024-04-10
13F-HR2024-02-14
13F-HR2023-11-14
SC 13D/A2023-09-08
13F-HR2023-08-14
3/A2023-05-24
13F-HR2023-05-15
32023-05-15
SC 13D2023-05-15

View Endurant Capital Management LP's complete filings history.

Compare quarters

Export Endurant Capital Management LP's holdings